Aspergillosis (Aspergillus fumigatus)

Aspergillosis is a common and often fatal fungal disease of birds, caused primarily by the saprophytic mold Aspergillus fumigatus, although other species such as A. flavus, A. niger, and A. terreus may also be involved. The disease manifests as a respiratory infection, with the formation of granulomatous lesions in the lungs, air sacs, and trachea, and can become disseminated to other organs. In psittacines (parrots, budgerigars), passerines (canaries, finches), and raptors (birds of prey), aspergillosis is a leading cause of morbidity and mortality, particularly in captive environments. The disease is characterized by a spectrum of clinical presentations, ranging from acute, rapidly fatal pneumonia to chronic, insidious granulomatous airsacculitis. Anatomically, the avian respiratory system is unique, with rigid lungs and extensive air sacs that extend into the coelomic cavity and bones, facilitating fungal spore deposition and colonization. The disease is often associated with immunosuppression, poor husbandry, and environmental contamination. Staging of aspergillosis is based on the location and extent of lesions, with early localized tracheal or air sac involvement carrying a better prognosis than disseminated disease.

The primary causative agent is Aspergillus fumigatus, a ubiquitous thermotolerant mold found in decaying organic matter, feed, bedding, and soil. Other Aspergillus species, including A. flavus, A. niger, A. terreus, and A. nidulans, have been isolated from avian lesions, but A. fumigatus accounts for over 90% of cases. The fungus produces conidia (spores) that are aerosolized and inhaled by birds. The conidia are small (2-3.5 µm) and can penetrate deep into the respiratory tract, reaching the lungs and air sacs. In immunocompromised birds, the conidia germinate into hyphae, which invade tissues and elicit a granulomatous inflammatory response. Environmental triggers include poor ventilation, high humidity, damp bedding, and the presence of moldy feed or nesting material. Dietary imbalances, such as vitamin A deficiency, can impair mucosal immunity and ciliary function, increasing susceptibility. Stress from overcrowding, transport, or concurrent disease also predisposes to infection. The fungus produces mycotoxins, including gliotoxin, which suppress the immune response and facilitate tissue invasion.

Aspergillosis affects a wide range of avian species, but certain groups are particularly susceptible. In psittacines, African grey parrots (Psittacus erithacus), Amazon parrots (Amazona spp.), and cockatoos (Cacatuidae) are commonly affected. Among passerines, canaries (Serinus canaria) and finches are vulnerable. Raptors, especially goshawks (Accipiter gentilis), red-tailed hawks (Buteo jamaicensis), and falcons (Falco spp.), are highly susceptible, often due to stress and captivity. Waterfowl, such as penguins and swans, are also at risk. The disease is more prevalent in captive birds than in wild populations, with incidence rates varying from 5% to 20% in some collections. Age predilection is variable; young birds may develop acute disease, while older birds often suffer chronic forms. Sex predilection is not significant. Husbandry factors, including poor ventilation, high humidity, and the use of moldy substrates, increase the risk. Wild birds may contract the disease from contaminated environments, but it is less common. The disease is not contagious between birds, as it is acquired from the environment.

The pathophysiology of aspergillosis begins with the inhalation of Aspergillus conidia. In healthy birds, the mucociliary apparatus and phagocytic activity of macrophages in the respiratory tract eliminate the spores. However, when the immune system is compromised or the fungal load is overwhelming, conidia germinate into hyphae within the lungs and air sacs. The hyphae invade the respiratory epithelium, causing necrosis and inflammation. The avian respiratory system is unique: the lungs are rigid and do not expand, and air sacs extend throughout the coelomic cavity and into bones. This anatomy allows fungal spores to spread rapidly. The immune response is characterized by a granulomatous reaction, with heterophils, macrophages, and multinucleated giant cells forming granulomas. These granulomas can obstruct airways, impair gas exchange, and lead to respiratory distress. Chronic infection may result in fibrosis and caseous necrosis. Dissemination can occur via the bloodstream or direct extension, affecting the liver, spleen, kidneys, and central nervous system. Fungal toxins, such as gliotoxin, further suppress the immune response and promote tissue damage. The disease can cause airsacculitis, pneumonia, tracheitis, and, in severe cases, systemic aspergillosis.

Intrinsic predisposing factors include species-specific anatomical and physiological traits. Birds with a high metabolic rate and efficient respiratory systems, such as raptors and psittacines, are more susceptible. Young birds and geriatric birds have less robust immune responses. Stress, whether from captivity, transport, or social interactions, suppresses immunity. Extrinsic factors are primarily environmental: poor ventilation, high humidity (above 60%), and temperatures that favor fungal growth (20-30°C). Contaminated feed, especially grains and seeds, and bedding materials like wood shavings or straw can harbor Aspergillus spores. Inadequate sanitation, such as infrequent cleaning of food and water bowls, increases spore load. Dietary deficiencies, particularly vitamin A, can impair mucosal integrity and ciliary function. Concurrent diseases, such as viral infections (e.g., circovirus) or parasitism, can immunosuppress the bird. Overcrowding and poor air quality (dust, ammonia) also contribute. In raptors, the use of inappropriate perches or feeding spoiled meat may increase risk.

Clinical signs of aspergillosis vary depending on the form. Acute aspergillosis, often seen in young birds or after heavy spore exposure, presents with sudden onset of dyspnea, tachypnea, cyanosis, and death within 24-48 hours. Chronic aspergillosis is more common and insidious, with signs developing over weeks to months. Affected birds may show lethargy, anorexia, weight loss, and depression. Respiratory signs include open-mouth breathing, tail bobbing, wheezing, and a change in voice or loss of voice (especially in psittacines). A common finding is a 'squeak' or 'click' on auscultation due to tracheal or syrinx lesions. Birds may also exhibit exercise intolerance and reluctance to fly. In raptors, a characteristic 'keek' sound may be heard. Gastrointestinal signs, such as regurgitation or diarrhea, can occur if the fungus spreads to the digestive tract. Neurological signs, including ataxia, seizures, or head tilt, may indicate central nervous system involvement. Physical examination may reveal poor body condition, dehydration, and abnormal respiratory sounds. In some cases, granulomas may be visible in the oral cavity or choana.

Differential diagnoses for aspergillosis include: 1) Bacterial pneumonia or airsacculitis (e.g., Chlamydia psittaci, Mycoplasma spp., Pasteurella multocida) - these often present with similar respiratory signs, but may respond to antibiotics; diagnosis via PCR or culture. 2) Mycobacteriosis (Mycobacterium avium) - chronic weight loss and granulomatous lesions; acid-fast staining and PCR differentiate. 3) Parasitic infections (e.g., Syngamus trachea in passerines, air sac mites in canaries) - direct visualization of parasites or eggs in feces. 4) Hypovitaminosis A - causes squamous metaplasia of respiratory epithelium, leading to respiratory signs; responds to vitamin A supplementation. 5) Foreign body inhalation - acute onset dyspnea; imaging or endoscopy may reveal a foreign object. 6) Neoplasia (e.g., pulmonary carcinoma) - chronic respiratory signs; imaging and biopsy. 7) Trauma (e.g., rib fractures) - acute respiratory distress; radiography. 8) Congestive heart failure - ascites and hepatomegaly; echocardiography. 9) Toxicity (e.g., zinc or lead poisoning) - neurological and gastrointestinal signs; blood lead/zinc levels. 10) Viral infections (e.g., avian influenza, Newcastle disease) - systemic signs; PCR and serology.

The diagnostic algorithm for aspergillosis begins with a thorough history and physical examination. Suspect aspergillosis in any bird with chronic respiratory signs, especially if husbandry is suboptimal. Step 1: Perform a complete physical exam, including auscultation of the respiratory tract. Step 2: Obtain blood samples for hematology and serum biochemistry. Venipuncture sites include the right jugular vein, basilic (wing) vein, and medial metatarsal vein, depending on species. Step 3: Perform radiography (whole-body dorsoventral and lateral views) to assess the respiratory system. Look for air sac opacification, granulomas, or tracheal narrowing. Step 4: If available, perform computed tomography (CT) for more detailed imaging. Step 5: Endoscopy is highly valuable; a rigid endoscope can visualize the trachea, syrinx, and air sacs, and allow biopsy of lesions. Step 6: Collect samples for cytology (impression smears of lesions) and histopathology (biopsy). Step 7: Perform fungal culture from tracheal wash, air sac aspirate, or biopsy material. Step 8: Serological tests, such as ELISA for Aspergillus antibodies or antigen (galactomannan), can support the diagnosis, but may have variable sensitivity. Step 9: PCR on tissue or fluid samples can confirm the presence of Aspergillus DNA. Step 10: In acute cases, necropsy may be necessary for definitive diagnosis.

Hematology often reveals leukocytosis with heterophilia and monocytosis. In chronic cases, non-regenerative anemia may be present. Serum biochemistry may show elevated aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) due to tissue damage. Bile acids may be elevated if the liver is involved. Uric acid may be elevated in renal involvement. Hypoalbuminemia and hyperglobulinemia are common. Fecal analysis is usually unremarkable, but may reveal secondary infections. Serology: ELISA for Aspergillus antibodies can be positive in chronic cases, but false negatives occur in immunocompromised birds. Antigen testing (galactomannan) is more sensitive for invasive disease. PCR on tracheal washes or biopsy samples is highly specific. Urinalysis is rarely performed in birds, but if obtained, may show urates and possibly fungal elements. In raptors, a 'buffy coat' smear may show fungal hyphae in severe cases.

Radiography: In early cases, radiographs may be normal. As the disease progresses, you may see increased opacity in the air sacs, loss of the normal air sac lucency, and the presence of soft tissue masses (granulomas) in the lungs or air sacs. The trachea may appear narrowed or have a soft tissue density. In chronic cases, there may be periosteal reaction on the bones if air sacs are involved. Ultrasonography: Coelomic ultrasound can detect granulomas in the liver, spleen, or kidneys, but is less useful for respiratory lesions. CT: Computed tomography is the imaging modality of choice for aspergillosis, providing detailed cross-sectional images of the lungs, air sacs, and trachea. It can detect small granulomas and assess the extent of disease. MRI: Magnetic resonance imaging is useful for evaluating central nervous system involvement. Endoscopy: Rigid endoscopy allows direct visualization of the trachea, syrinx, and air sacs. Typical findings include white to yellow caseous plaques, granulomas, and inflammation. Biopsies can be taken during endoscopy.

Cytology: Impression smears of granulomas or tracheal washes may reveal septate, branching fungal hyphae (characteristic of Aspergillus) with acute inflammation (heterophils and macrophages). Stains such as Diff-Quik or Gram stain can highlight the hyphae. Histopathology: Biopsy samples show granulomatous inflammation with central necrosis, surrounded by heterophils, macrophages, and multinucleated giant cells. Fungal hyphae are visible with special stains such as Gomori methenamine silver (GMS) or Periodic acid-Schiff (PAS). The hyphae are septate and branch at acute angles (45°). In chronic lesions, fibrosis and mineralization may be present. The presence of fungal hyphae within tissues confirms the diagnosis.

Treatment of aspergillosis is challenging and requires a multi-modal approach. Emergency stabilization: If the bird is dyspneic, provide oxygen supplementation in a quiet, stress-free environment. Fluid therapy: Administer subcutaneous or intravenous fluids (e.g., Lactated Ringer's solution) at 50-100 ml/kg/day, depending on hydration status. Assisted nutrition: If anorexic, provide syringe feeding with a critical care formula (e.g., Oxbow Critical Care) at 1-2% body weight per feeding, 3-4 times daily. Primary medical therapy: Antifungal drugs are the cornerstone. Itraconazole (10 mg/kg PO q24h) is commonly used, but may be hepatotoxic; monitor liver enzymes. Voriconazole (12.5-20 mg/kg PO q12h) is more effective but expensive. Amphotericin B (1.5 mg/kg IV q8h) can be used for severe cases, but is nephrotoxic. Nebulization with clotrimazole (20 mg/ml) or enilconazole (10 mg/ml) can deliver drug directly to the respiratory tract. Surgical intervention: In cases with tracheal or syrinx granulomas, surgical debulking via endoscopy or surgery may be necessary. Husbandry corrections: Improve ventilation, reduce humidity, and remove moldy materials. Provide a clean, dry environment. Supportive care: Vitamin A supplementation (10,000 IU/kg PO q24h) may help restore mucosal integrity. Treatment should continue for weeks to months, with regular rechecks.

The prognosis for aspergillosis varies. Acute cases with severe respiratory compromise have a poor prognosis, with high mortality despite treatment. Chronic localized cases (e.g., tracheal granuloma) have a fair to good prognosis if treated aggressively and early. Disseminated disease carries a guarded to poor prognosis. Negative prognostic indicators include severe weight loss, marked leukocytosis, hypoproteinemia, and involvement of multiple organs. Response to treatment is monitored by clinical improvement, resolution of respiratory signs, and reduction in lesion size on imaging. Birds that respond within 2-4 weeks have a better chance of recovery. However, recurrence is possible, especially if husbandry is not corrected. Long-term management may require periodic antifungal therapy and environmental control.

Follow-up should be structured. Recheck the bird every 2-4 weeks during initial treatment. At each visit, perform a physical exam, weigh the bird, and assess respiratory function. Repeat hematology and serum biochemistry to monitor for drug toxicity and response. Radiographs or CT should be repeated every 4-8 weeks to evaluate lesion resolution. Endoscopy may be repeated to assess tracheal or air sac lesions. After clinical resolution, continue antifungal therapy for at least 4-6 weeks. Then, taper the dose gradually. Long-term monitoring every 3-6 months is recommended for chronic cases. Husbandry audits should be performed to ensure optimal environmental conditions. Educate owners on the importance of cleanliness, ventilation, and avoiding moldy feed.

Pearls: 1) In psittacines, a change in voice or a 'squeak' is a classic early sign of tracheal aspergillosis. 2) Raptors often present with a 'keek' sound and exercise intolerance. 3) Endoscopy is the most reliable diagnostic tool; visualize the trachea and air sacs. 4) Voriconazole is the drug of choice for severe cases, but itraconazole is more cost-effective. 5) Nebulization with clotrimazole is an excellent adjunctive therapy. 6) Always correct husbandry; without it, treatment will fail. Pitfalls: 1) Do not use corticosteroids, as they exacerbate the infection. 2) Avoid using fluconazole, as it has poor efficacy against Aspergillus. 3) Do not rely solely on serology; false negatives are common. 4) Be cautious with itraconazole in African grey parrots, as they are sensitive to its hepatotoxic effects. 5) Do not forget to monitor for secondary bacterial infections. 6) Never use fipronil in birds, as it is toxic.

Based on Carpenter's Exotic Animal Formulary (6th edition): Itraconazole: 10 mg/kg PO q24h for 60-90 days (psittacines); 5-10 mg/kg PO q24h (raptors). Voriconazole: 12.5-20 mg/kg PO q12h (psittacines); 20 mg/kg PO q12h (raptors). Amphotericin B: 1.5 mg/kg IV q8h for 3-5 days, then taper; or 1 mg/kg intratracheal. Clotrimazole: 20 mg/ml, nebulize 15-20 minutes q12h. Enilconazole: 10 mg/ml, nebulize 15-20 minutes q12h. Fluconazole: not recommended. Terbinafine: 15-25 mg/kg PO q12h (may be used in combination). Supportive: Vitamin A: 10,000 IU/kg PO q24h. Fluids: Lactated Ringer's solution at 50-100 ml/kg/day SC or IV. Nutritional support: Critical Care formula at 1-2% body weight per feeding, 3-4 times daily.

Aspergillosis is extensively studied in avian medicine. Key references include: Quesenberry & Carpenter's 'Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery' (but for birds, refer to 'Avian Medicine and Surgery' by Samour). Carpenter's 'Exotic Animal Formulary' provides current drug dosages. A landmark study by Beernaert et al. (2010) evaluated the efficacy of voriconazole in psittacines, showing high success rates. Another study by Van Waeyenberghe et al. (2012) compared itraconazole and voriconazole in falcons, finding voriconazole superior. The AAV (Association of Avian Veterinarians) has published consensus guidelines on the diagnosis and treatment of aspergillosis. A retrospective study by Jones and Orosz (2000) reported a 50% survival rate in chronic cases with aggressive therapy. Recent research focuses on the use of nebulized amphotericin B and the role of immunomodulation. The use of PCR for early diagnosis is gaining popularity. Overall, early diagnosis and aggressive treatment, combined with environmental correction, are key to successful outcomes.